Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Fluvoxamine, sold under the brand name Luvox among others, is an antidepressant of the selective serotonin reuptake inhibitor (SSRI) class. It is primarily used to treat major depressive disorder and, perhaps more especially, obsessive–compulsive disorder (OCD), but is also used to treat anxiety disorders such as panic disorder, social anxiety disorder…
History, Applications, Research & Standards
Explore the main themes, entities and connections around Fluvoxamine. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
may ssris effects ssri serotonin anxiety also treatment sexual drug etc dysfunction reuptake ocd risk cyp2d6 cyp1a2 mg disorder social
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Fluvoxamine | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Fluvoxamine | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Fluvoxamine | ATC code | N06AB08 (WHO) | 1.00 | infobox |
| Fluvoxamine | Bioavailability | 53% (90% confidence interval: 44–62%) | 1.00 | infobox |
| Fluvoxamine | CAS Number | 54739-18-3 Y | 1.00 | infobox |
| Fluvoxamine | ChEBI | CHEBI:5138 Y | 1.00 | infobox |
| Fluvoxamine | ChEMBL | ChEMBL814 Y | 1.00 | infobox |
| Fluvoxamine | ChemSpider | 4481878 Y | 1.00 | infobox |
| Fluvoxamine | CompTox Dashboard (EPA) | DTXSID2044002 | 1.00 | infobox |
| Fluvoxamine | Drug class | Selective serotonin reuptake inhibitor (SSRI) | 1.00 | infobox |
| Fluvoxamine | DrugBank | DB00176 N | 1.00 | infobox |
| Fluvoxamine | ECHA InfoCard | 100.125.476 | 1.00 | infobox |
| Fluvoxamine | Elimination half-life | 12–13 hours (single dose), 22 hours (repeated dosing) | 1.00 | infobox |
| Fluvoxamine | Excretion | Kidney (98%; 94% as metabolites, 4% as unchanged drug) | 1.00 | infobox |
| Fluvoxamine | Formula | C15H21F3N2O2 | 1.00 | infobox |
| Fluvoxamine | IUPHAR/BPS | 7189 | 1.00 | infobox |
| Fluvoxamine | KEGG | D07984 Y | 1.00 | infobox |
| Fluvoxamine | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Fluvoxamine | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Fluvoxamine | Legal status | CA: ℞-only | 1.00 | infobox |
| Fluvoxamine | Legal status | UK: POM (Prescription only) | 1.00 | infobox |
| Fluvoxamine | Legal status | US: ℞-only | 1.00 | infobox |
| Fluvoxamine | License data | US DailyMed: Fluvoxamine | 1.00 | infobox |
| Fluvoxamine | MedlinePlus | a695004 | 1.00 | infobox |
| Fluvoxamine | Metabolism | Liver (primarily O-demethylation) Major: CYP2D6 or CYP1A2 Minor: CYP3A4, CYP2C19, and/or CYP1A2 | 1.00 | infobox |
| Fluvoxamine | Molar mass | 318.340 g·mol−1 | 1.00 | infobox |
| Fluvoxamine | Pregnancy category | AU: C | 1.00 | infobox |
| Fluvoxamine | Pronunciation | floo-VAHK-sə-meen UK: /fluːˈvɒksəmiːn/ US: /fluːˈvɑːksəˌmiːn/ | 1.00 | infobox |
| Fluvoxamine | Protein binding | 77–80% | 1.00 | infobox |
| Fluvoxamine | PubChem CID | 5324346 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.